Literature DB >> 12196230

Comparison of cost and outcome of endovascular and neurosurgical procedures in the treatment of ruptured intracranial aneurysms.

Phillip Bairstow1, Andrew Dodgson, Jennie Linto, Mark Khangure.   

Abstract

Endovascular techniques for the treatment of intracranial aneurysms have gained rapid acceptance in some countries as an alternative to conventional neurosurgical treatment. The International Subarachnoid Aneurysm Trial (ISAT) is the first multicentre prospective randomized trial comparing neurosurgery with endovascular coil (Guglielmi detachable coil) treatment of acute subarachnoid haemorrhage. The cost and outcome of endovascular procedures was compared with neurosurgical procedures in the treatment of ruptured intracranial aneurysms within the context of the ISAT. Two groups of patients (Endovascular group with 10 patients and the Neurosurgical group with 12 patients) were drawn from admissions to Royal Perth Hospital and Sir Charles Gairdner Hospital, Perth, Western Australia, as detailed in the ISAT trial protocol. Data were collected in the following categories: patient, procedure, hospitalization, morbidity and mortality. While the endovascular procedure tended to be the more expensive in terms of the cost of consumables, this expense was more than compensated by savings in staffing costs, and the period and cost of hospitalization. Following an endovascular procedure, patients tended to return to normal activity or paid employment sooner and have a favourable functional outcome compared with patients following a neurosurgical procedure.

Entities:  

Mesh:

Year:  2002        PMID: 12196230     DOI: 10.1046/j.1440-1673.2002.01053.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  8 in total

1.  A predictive model of hospitalization cost after cerebral aneurysm clipping.

Authors:  Kimon Bekelis; Symeon Missios; Todd A MacKenzie; Nicos Labropoulos; David W Roberts
Journal:  J Neurointerv Surg       Date:  2015-01-12       Impact factor: 5.836

2.  A Nationwide Analysis of Aneurysmal Subarachnoid Hemorrhage Mortality, Complications, and Health Economics in the USA.

Authors:  Lefko T Charalambous; Syed M Adil; Shashank Rajkumar; Robert Gramer; Elayna Kirsch; Beiyu Liu; Ali Zomorodi; Mark McClellan; Shivanand P Lad
Journal:  Transl Stroke Res       Date:  2022-07-26       Impact factor: 6.800

3.  Cost-Effectiveness Analysis of Endovascular Coiling versus Neurosurgical Clipping for Intracranial Aneurysms in Republic of Korea.

Authors:  Hyuk Won Chang; Shang Hun Shin; Sang Hyun Suh; Bum-Soo Kim; Myung Ho Rho
Journal:  Neurointervention       Date:  2016-09-03

4.  Coil embolization for intracranial aneurysms: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-01-01

5.  Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States.

Authors:  Alberto Maud; Kamakshi Lakshminarayan; M Fareed K Suri; Gabriela Vazquez; Giuseppe Lanzino; Adnan I Qureshi
Journal:  J Neurosurg       Date:  2009-05       Impact factor: 5.115

6.  Treatment of aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysms by neurosurgeons in Colombia: A survey.

Authors:  Gabriel Alcalá-Cerra; Juan J Gutiérrez Paternina; María E Buendía de Ávila; Edgar I Preciado Mesa; Rubén Sabogal Barrios; Lucía M Niño-Hernández; Keith Suárez Jaramillo
Journal:  Surg Neurol Int       Date:  2011-09-17

7.  Cost-effectiveness of CTA, MRA and DSA in patients with non-traumatic subarachnoid haemorrhage.

Authors:  Anna M H Sailer; Janneke P Grutters; Joachim E Wildberger; Paul A Hofman; Jan T Wilmink; Willem H van Zwam
Journal:  Insights Imaging       Date:  2013-07-10

8.  Cost of Treatment of Cerebral Aneurysm Embolization: Study of Associated Factors.

Authors:  Amine Cheikh; Razine Rachid; Aasfara Jehanne; Ababou Adil; Benomar Ali; Yahya Cherrah; El Hassani Amine; El Quessar Abdeljalil
Journal:  Neurol Ther       Date:  2016-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.